ArticleOncology reports2023

NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia.

Xiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.